Intouch Solutions

APRIL 3, 2024

When we hear the topic “Modular Content and MLR Relationship,” we think and hear of the challenges with medical, legal and regulatory (MLR). Marketers are under immense pressure because omnichannel puts more demands on marketing to produce more content.

Marketing 59

Marketing 59

Outsourcing Pharma

MAY 25, 2022

Michelle Keefe, formerly the president of medical affairs and commercial solutions, joined the company in 2017; she also had spent 20 years working for Pfizer.

Regulation 52

Regulation Marketing 52

Syneos Health

JUNE 16, 2022

Wherever you are in your Medical Affairs journey … … We are uniquely capable of offering both standalone and integrated solutions that can lead to greater clinical and commercial success

52

52

Drug Discovery World

APRIL 8, 2024

In this free webinar, you will hear from Dr Jill O’Donnell-Tormey, CEO and Director of Scientific Affairs at Cancer Research Institute; Dr Roger Levy, Senior Global Medical Director, GSK Specialty Medicine; Dr Sheila Keating, VP of Immunology at Gigagen; as well as event sponsors Dr Milind Nigam, Leader – Scientific Solutions Consulting (..)

Antibody 59

Antibody Marketing Gene Therapy Engineer 59

pharmaphorum

MARCH 26, 2021

Designed for the pharma and life sciences industries, it offers significant industry-specific advantages over general document authoring solutions in the market today. While customers will have the choice to deploy doDOC standalone, the solution will be integrated with Envision’s leading medical affairs platform, iEnvision.

Life Science 58

Life Science Branding Marketing Development 58

pharmaphorum

APRIL 11, 2022

Janssen’s Catherine Taylor, vice-president, EMEA medical affairs, therapy area strategy, discusses the importance of systemic innovation across the healthcare system to realise the full value of medicines. How can innovation within Medical Affairs drive value? About the author.

Medicine 109

Medicine Clinical Trials Clinical Trials Development 109

Pharma Marketing Network

JULY 17, 2023

He has pervasive consultative experience partnering with brand teams, medical affairs, and training departments, to provide innovative solutions and solve complex challenges. Randy Compton is a 20+year veteran of the Pharmaceutical marketing, sales, strategy, and product development industry.

Branding 52

Branding Sales Marketing Production 52

Cloudbyz

APRIL 12, 2022

Cloudbyz , makers of digital clinical research management solutions natively built and run on the Salesforce platform is headquartered in Naperville, Illinois. Organizations committed to clinical research will benefit immensely from the combination of the Cloudbyz solution portfolio and ClinChoice’s clinical research services.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Research 52

pharmaphorum

JUNE 16, 2022

In this episode of the pharmaphorum podcast, editor in chief Jonah Comstock welcomes Dr. Jennifer Jones-McMeans, divisional vice president for global affairs for Abbott’s vascular business to discuss diversity and equity in clinical trials.

Clinical Trials 97

Clinical Trials Clinical Trials Trials 97

Pharma Marketing Network

DECEMBER 6, 2023

Reuters Events: Pharma USA 2024 is where senior pharma executives from Commercial, Marketing, Medical Affairs, RWE, Market Access, Patient Engagement, as well as key stakeholders, will come together to map out how they can deliver value to overcome the challenges that are hindering scientific innovation. 

Regulation 52

Regulation Marketing Medicine Development 52

Clinical Trial Podcast

APRIL 23, 2023

In light of the EU Medical Device Regulation (MDR), medical device manufacturers are required to implement a Postmarket Surveillance (PMS) plan, which in turn may require them to conduct Postmarket Surveillance Studies. In this episode, we’re going to talk about Postmarket Surveillance Studies.

Clinical Trials 52

Clinical Trials Clinical Trials Regulation Production 52

Intouch Solutions

NOVEMBER 11, 2021

Good news, though – Intouch Group has the solution for brands struggling to connect: Intouch MedComm. Innovation has been part of Intouch since day one, and over the years, we’ve been applying that innovative mindset across the commercial lifecycle, employing our medical communications services to transform dozens of products.

Branding 52

Branding Production Marketing Development 52

XTalks

MARCH 7, 2024

Charlotte Owens, Head of Medical Affairs and Outcomes Research at Organon Organon, a global healthcare company renowned for its dedication to improving women’s health, has recently taken a significant stride with the launch of its “ Her Plan is Her Power ” initiative in the US.

Production 102

Production Research Medicine 102

Pharmaceutical Technology

DECEMBER 27, 2022

Our response to the worldwide pandemic evolved over time, and so did the needs of the sector and the people relying on healthcare companies to deliver solutions. William explored the unique state of affairs when it comes to drug development for such n=1 ultra-rare diseases. Tracking the news. Tracking drug development. See you in 2023!

Clinical Trials 306

Clinical Trials Clinical Trials Trials Vaccination 306

Drug Discovery World

APRIL 22, 2024

In this free webinar, you will hear from Dr Jill O’Donnell-Tormey, CEO and Director of Scientific Affairs at Cancer Research Institute; Dr Roger Levy, Senior Global Medical Director, GSK Specialty Medicine; Dr Sheila Keating, VP Immunology at Gigagen; as well as event sponsors Dr Milind Nigam, Leader – Scientific Solutions Consulting at (..)

Antibody 52

Antibody Development Gene Therapy Marketing 52

pharmaphorum

DECEMBER 15, 2022

Capturing Medical Insights With Zero-Risk. When capturing medical and field insights you have to comply with numerous regulations relevant to the world of data privacy – a challenge often compounded by the many different variables that govern the process of insight capture and analysis. What is the KOL location? w : [link].

Regulation 52

Regulation Compliance Pharma Companies Business Development 52

pharmaphorum

APRIL 15, 2021

“Our mission is to turn innovative science into value for patients and we are working in a lot of different areas with high unmet need,” says Stef Schutte, Astellas’ head of regulatory affairs. “We By doing that, regulatory affairs professionals help guide the development and lifecycle of a therapy.”. A strategic partner.

Development 61

Development Manufacturing Production Bioinformatics 61

Drug Discovery World

APRIL 15, 2024

In this free webinar, you will hear from Dr Jill O’Donnell-Tormey, CEO and Director of Scientific Affairs at Cancer Research Institute; Dr Roger Levy, Senior Global Medical Director, GSK Specialty Medicine; Dr Sheila Keating, VP Immunology at Gigagen; as well as event sponsors Dr Milind Nigam, Leader – Scientific Solutions Consulting at (..)

Antibody 52

Antibody Marketing Gene Therapy Engineer 52

pharmaphorum

AUGUST 17, 2021

AXON is expecting to make several appointments in the US in the coming months to support existing clients and potential new opportunities, as we expand our work in medical affairs, clinical trial services, HEOR and real-world evidence, and public relations. About AXON.

Clinical Trials 98

Clinical Trials Clinical Trials Branding Marketing 98

pharmaphorum

MARCH 22, 2022

We show how companies can leverage and create efficiencies from the full scope of available data obtainable within each of its teams, whether medical affairs, market access , or GHEORE,” says Cherian.

Development 52

Development Marketing Production Research 52

Drug Discovery World

APRIL 8, 2024

In this free webinar, you will hear from Dr Jill O’Donnell-Tormey, CEO and Director of Scientific Affairs at Cancer Research Institute; Dr Roger Levy, Senior Global Medical Director, GSK Specialty Medicine; Dr Sheila Keating, VP Immunology at Gigagen; as well as event sponsors Dr Milind Nigam, Leader – Scientific Solutions Consulting at (..)

Antibody 52

Antibody Marketing Gene Therapy Engineer 52

pharmaphorum

OCTOBER 12, 2022

Understand the latest regulatory requirements from regulatory experts surrounding medical devices and digital health. Speakers Include: Sebastian Stening, Vice President and Global Head Medical Device Manufacturing Science and Technology, Bayer. Abha Violette, Associate Director, Medical Devices and Combination Products, AstraZeneca.

Drugs 52

Drugs Packaging Packaging Drug Delivery 52

pharmaphorum

JULY 27, 2022

Health innovation and technology specialist Healthware Group has added another element to its business with the launch of a dedicated medical communications and education division. “Medical Affairs is now a strategic focus alongside R&D, commercial and market access,” said Namouk of his new role.

Doctors 98

Doctors Doctor Marketing 98

Intouch Solutions

NOVEMBER 11, 2021

Addition of Intouch MedComm Enables Firm to Deliver Digitally Savvy Science Solutions to Scale Client Business Growth. Intouch has been creating effective medical communications since its inception in 1999. Medical Communications service offerings have increasingly become a critical part of the marketing mix for Intouch clients.

Life Science 52

Life Science Branding Marketing 52

pharmaphorum

NOVEMBER 18, 2020

Scientific communications company Envision Pharma has bought Two Labs, a firm specialising in commercial solutions for the pharma and biotech sector, for an undisclosed sum. The post Envision acquires commercial solutions firm Two Labs appeared first on.

Production 71

Production Marketing Development Sales 71

pharmaphorum

DECEMBER 23, 2022

Rarely are organisations able to view HCP relationships holistically – across clinical, medical, and sales – or reap the benefits of creating a unified understanding of the customer. Medical will become the cornerstone connecting R&D and commercial. A unified view of the HCP will emerge from clinical to commercial.

Sales 98

Sales Marketing Life Science Compliance 98

Cloudbyz

APRIL 19, 2021

Cloudbyz has positioned itself as a reputable and highly preferred CTMS solution provider in the life science domain. Cloudbyz was approached by a medical technology company. Our client is a globally renowned American medical technology enterprise specializing in manufacturing cardiovascular products and services.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Life Science 52

pharmaphorum

APRIL 4, 2022

Zaid brings a decade of experience in the medical sector, with seven years of experience in medical insights and strategy. Well-designed and well-executed research initiatives will uncover the barriers and solutions necessary to help clients remedy communication shortcomings.

Branding 58

Branding Marketing Research Medicine 58

pharmaphorum

MAY 5, 2022

Benefits of Attending: •Engage with key regulatory updates surrounding digital health and medical devices. Regulatory Affairs. Medical Device Data. Device Safety Solution Providers. •or or anyone who works with Wearable Devices/ On-Body Injectors within pharmaceuticals, biotech, device developers and solution providers.

Drug Delivery 52

Drug Delivery Packaging Packaging Development 52

XTalks

APRIL 19, 2024

Avicenna.AI , a leading medical imaging AI company, has received US Food and Drug Administration (FDA) 510(k) clearance for two of its AI-based tools, CINA-iPE and CINA-ASPECTS, which are designed to enhance the diagnosis and assessment of pulmonary embolism and stroke severity, respectively, via CT scans. percent and 24.2

Marketing 52

Marketing Radiology Development Manufacturing 52

Pharmaceutical Technology

SEPTEMBER 2, 2022

Flexible commercialisation solutions, throughout the lifecycle. From the go-to-market strategy and regulatory affairs to distribution and medical outreach, many activities are required to successfully commercialise a product in a new country.

Drugs 130

Drugs Pharma Companies Sales Production 130

Drug Discovery World

NOVEMBER 17, 2022

Amit Aggarwal, Executive Director, Medical Affairs, said: “Antibiotic resistance is a silent threat to the very foundations of modern medicine. In England, during 2019/20, there were over 90,000 hospital admissions – yet the global pipeline for new antibiotics to address this growing problem has been failing. .

Bacteria 52

Bacteria Development Medicine Drugs 52

Clinical Trial Podcast

FEBRUARY 23, 2021

Clinical Research is sometimes also referred to as Medical Affairs or Clinical Affairs. This is true for pharmaceuticals, medical devices, and biologics. Government agencies, medical community, and patients believe in the power of data. The safety team reviews reported AEs and collects relevant medical records.

Clinical Research 105

Clinical Research Research Clinical Trials Clinical Trials 105

pharmaphorum

DECEMBER 11, 2022

Dr Yacine Hadjiat is global head of Biogen Digital Health Solutions. For instance, Biogen has developed a solution called Konectom, a smartphone-based platform that employs active and passive monitoring to collect neurological function data, such as motor control and mobility, on patients with CNS conditions. “If

Life Science 135

Life Science Clinical Research Development Research 135

pharmaphorum

JANUARY 18, 2022

Sponsors are: SCHOTT, ZEON, Owen Mumford Pharmaceutical Services, PHC Corporation, POLYPLASTICS- TOPAS, Weiss-Aug Group, Baumann Medical, BD Medical, West Pharmaceutical Services. Director, Head of Global Regulatory Affairs – Devices and Combination Products, Takeda. Guerin, Associate Director, Regulatory Affairs – CMC, Janssen.

Drug Delivery 52

Drug Delivery Production Drug Delivery Systems Packaging 52

pharmaphorum

DECEMBER 9, 2021

She rotated through regulatory affairs, external innovation, and self-care R&D. Each has its own innovation priorities, based on strong science and consumer need and these interests currently include novel delivery forms in allergy, devices for pain treatment and chronic pain solutions.

Allergies 103

Allergies Life Science Development Scientist 103

pharmaphorum

NOVEMBER 19, 2020

By adopting a design-led, solutions-based approach to communications, companies can help healthcare professionals (HCPs) to better meet the needs of their patients through their comms, taking a scientific approach to creating clear, rational processes built on discovery, definition, development, and delivery in every aspect of healthcare.

Compliance 73

Compliance Marketing Sales Development 73